Grueninger S: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) Β |
||
(One intermediate revision by the same user not shown) | |||
Line 2: | Line 2: | ||
|lastname=GrΓΌninger | |lastname=GrΓΌninger | ||
|firstname=Stephan | |firstname=Stephan | ||
|title=Dr. | |||
|institution=Novartis Pharma AG, Werk Klybeck | |||
|address=Klybeckstrasse 141 | |||
|area code=CH-4057 | |||
|city=Basel | |||
|country=Switzerland | |||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at== | |||
::::* [[IOC39|IOC39 Schroecken AT]] |
Latest revision as of 16:25, 12 February 2018
Name | GrΓΌninger Stephan, Dr. |
---|---|
Institution | Novartis Pharma AG, Werk Klybeck |
Address | Klybeckstrasse 141, CH-4057 |
City | Basel |
State/Province | |
Country | Switzerland |
[email protected] | |
Weblink | |
O2k-Network Lab | CH Basel Balavenkatraman KK |
Labels:
Publications
Add references to your publications